Results 41 to 50 of about 519 (143)

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency

open access: yesCase Reports in Pediatrics, Volume 2018, Issue 1, 2018., 2018
Mevalonate kinase deficiency (MKD) is a severe autoinflammatory disease caused by recessive mutations in MVK resulting in reduced function of the enzyme mevalonate kinase, involved in the cholesterol/isoprenoid pathway. MKD presents with periodic episodes of severe systemic inflammation, poor quality of life, and life‐threatening sequelae if ...
Nadia K. Rafiq   +5 more
wiley   +1 more source

Variable clinical phenotypes of alpha‐methylacyl‐CoA racemase deficiency: Report of four cases and review of the literature

open access: yesJIMD Reports, Volume 65, Issue 5, Page 305-312, September 2024.
Abstract Alpha‐methylacyl‐CoA‐racemase (AMACR) deficiency (MIM#604489) is a peroxisomal disorder resulting in the accumulation of pristanic acid, dihydroxycholestanoic acid (DHCA), and trihydroxycholestanoic acid (THCA), with variable clinical features and age of onset from infancy to late adulthood.
Arzu Selamioğlu   +10 more
wiley   +1 more source

Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases

open access: yesImmunology &Cell Biology, Volume 94, Issue 10, Page 994-999, November/December 2016., 2016
Mevalonate kinase deficiency (MKD) is caused by mutations in a key enzyme of the mevalonate–cholesterol biosynthesis pathway, leading to recurrent autoinflammatory disease characterised by enhanced release of interleukin‐1β (IL‐1β). It is currently believed that the inflammatory phenotype of MKD is triggered by temperature‐sensitive loss of mevalonate ...
Julie Jurczyluk   +13 more
wiley   +1 more source

Updates on clinical and laboratory aspects of hereditary dyserythropoietic anemias

open access: yesInternational Journal of Laboratory Hematology, Volume 46, Issue 4, Page 595-605, August 2024.
This review focuses on recent advancements in the field of hereditary dyserythropoietic anemias and provides a gene‐based classification of this heterogeneous group of genetic disorders. Abstract Hereditary dyserythropoietic anemias, or congenital dyserythropoietic anemias (CDAs), are rare disorders disrupting normal erythroid lineage development ...
Roberta Russo   +4 more
wiley   +1 more source

Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis

open access: yes, 2013
Mevalonic aciduria, a rare autosomal recessive disease, represents the most severe form of the periodic fever, known as Mevalonate Kinase Deficiency. This disease is caused by the mutation of the MVK gene, which codes for the enzyme mevalonate kinase ...
MARCUZZI, ANNALISA   +9 more
core   +1 more source

Identification of FDA‐approved drugs that increase mevalonate kinase in hyper IgD syndrome

open access: yesJournal of Inherited Metabolic Disease, Volume 47, Issue 2, Page 302-316, March 2024.
Abstract Mevalonate kinase deficiency (MKD) is an autoinflammatory metabolic disorder caused by bi‐allelic loss‐of‐function variants in the MVK gene, resulting in decreased activity of the encoded mevalonate kinase (MK). Clinical presentation ranges from the severe early‐lethal mevalonic aciduria to the milder hyper‐IgD syndrome (MKD–HIDS), and is in ...
Frouwkje A. Politiek   +4 more
wiley   +1 more source

Characterization of novel mevalonate kinases from the tardigrade Ramazzottius varieornatus and the psychrophilic archaeon Methanococcoides burtonii

open access: yesActa Crystallographica Section D, Volume 80, Issue 3, Page 203-215, March 2024.
This work reports the purification, biochemical characterization and high‐resolution structures of two novel mevalonate kinases: one from the extremotolerant tardigrade Ramazzottius varieornatus at 2 Å resolution and one from the psychrophilic archaeon Methanococcoides burtonii at 2.2 Å resolution.Mevalonate kinase is central to the isoprenoid ...
Lygie Esquirol   +6 more
wiley   +1 more source

Mevalónová acidúria / Mevalonic aciduria

open access: yes
Súhrn Mevalónová acidúria (OMIM#610377) je zriedkavá dedičná metabolická porucha zapríčinená deficitom mevalonátkinázy, ktorá katalyzuje jednu z prvých reakcií pri biosyntéze cholesterolu a iných nesteroidných izoprenoidov. V závislosti od reziduálnej aktivity enzýmu sa  klinicky manifestuje ako  mevalónová acidúria alebo hyper-IgD syndróm (HIDS ...
Slabá, Lucia   +7 more
openaire   +3 more sources

Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum

open access: yes, 2003
OBJECTIVE: Mevalonic aciduria as a result of mevalonate kinase deficiency is an inborn error of cholesterol biosynthesis characterized by dysmorphology, psychomotor retardation, progressive cerebellar ataxia, and recurrent febrile crises, usually ...
Zundel, Dorothee   +17 more
core   +1 more source

Periodic Fever Syndrome and Developmental Delay

open access: yes, 2019
The key to diagnosis of mevalonate kinase deficiency, hyper-IgD syndrome (MKD/HIDS) is recurrent fever attacks of 4–6 days, associated with aphthous stomatitis, enlargement of lymph nodes, splenomegaly, abdominal pain, diarrhea, and rash MKD is a rare ...
Berg, Stefan,   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy